ATE438385T1 - Pharmazeutische zusammensetzung - Google Patents

Pharmazeutische zusammensetzung

Info

Publication number: ATE438385T1
Authority: AT; Austria
Prior art keywords: composition; microparticle; pharmaceutical composition; production; ifn
Prior art date: 2005-03-02

Application number

AT06709975T

Other languages

English (en)

Inventor

James Edward Eyles

Angela Westwood

Stephen Elvin

Gareth David Healey

Original Assignee

Secr Defence

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-02

Filing date

2006-03-02

Publication date

2009-08-15

2005-03-02 Priority claimed from GB0504276A external-priority patent/GB0504276D0/en

2005-06-10 Priority claimed from GB0511801A external-priority patent/GB0511801D0/en

2006-03-02 Application filed by Secr Defence filed Critical Secr Defence

2009-08-15 Application granted granted Critical

2009-08-15 Publication of ATE438385T1 publication Critical patent/ATE438385T1/de

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
239000011859 microparticle Substances 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
102000006992 Interferon-alpha Human genes 0.000 abstract 1
108010047761 Interferon-alpha Proteins 0.000 abstract 1
229920002988 biodegradable polymer Polymers 0.000 abstract 1
239000004621 biodegradable polymer Substances 0.000 abstract 1
210000004443 dendritic cell Anatomy 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000028993 immune response Effects 0.000 abstract 1
230000002163 immunogen Effects 0.000 abstract 1
229920002521 macromolecule Polymers 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 abstract 1
229920002477 rna polymer Polymers 0.000 abstract 1
239000003381 stabilizer Substances 0.000 abstract 1
230000004936 stimulating effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/07—Bacillus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT06709975T 2005-03-02 2006-03-02 Pharmazeutische zusammensetzung ATE438385T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0504276A GB0504276D0 (en)	2005-03-02	2005-03-02	Pharmaceutical composition
GB0511801A GB0511801D0 (en)	2005-06-10	2005-06-10	Pharmaceutical composition
PCT/GB2006/000751 WO2006092607A1 (en)	2005-03-02	2006-03-02	Pharmaceutical composition

Publications (1)

Publication Number	Publication Date
ATE438385T1 true ATE438385T1 (de)	2009-08-15

Family

ID=36353665

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06709975T ATE438385T1 (de)	2005-03-02	2006-03-02	Pharmazeutische zusammensetzung

Country Status (8)

Country	Link
US (1)	US20080138431A1 (de)
EP (1)	EP1853227B1 (de)
JP (1)	JP2008531672A (de)
AT (1)	ATE438385T1 (de)
AU (1)	AU2006219717B2 (de)
CA (1)	CA2599329A1 (de)
DE (1)	DE602006008278D1 (de)
WO (1)	WO2006092607A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2480775C (en)	2002-04-04	2016-05-31	Coley Pharmaceutical Gmbh	Immunostimulatory g,u-containing oligoribonucleotides
ES2536103T3 (es)	2005-11-25	2015-05-20	Zoetis Belgium S.A.	Oligorribonucleótidos inmunoestimuladores
CN102170903B (zh) *	2008-05-02	2016-04-06	亮点医疗有限公司	用于刺激免疫反应的产品和方法
AU2011276234B2 (en)	2010-07-06	2016-02-25	Glaxosmithkline Biologicals S.A.	Liposomes with lipids having an advantageous pKa- value for RNA delivery
SI2591114T1 (sl)	2010-07-06	2016-10-28	Glaxosmithkline Biologicals S.A.	Imunizacija velikih sesalcev z majhnimi odmerki RNA
ES2646669T3 (es)	2010-07-06	2017-12-14	Glaxosmithkline Biologicals Sa	Procedimientos de aumento de una respuesta inmunitaria mediante el suministro de ARN
US9770463B2 (en) *	2010-07-06	2017-09-26	Glaxosmithkline Biologicals Sa	Delivery of RNA to different cell types
US11291635B2 (en)	2010-07-06	2022-04-05	Glaxosmithkline Biological Sa	Virion-like delivery particles for self-replicating RNA molecules
WO2012031043A1 (en)	2010-08-31	2012-03-08	Novartis Ag	Pegylated liposomes for delivery of immunogen-encoding rna
EP3520813B1 (de)	2010-10-11	2023-04-19	GlaxoSmithKline Biologicals S.A.	Antigenfreisetzungsplattformen
EP3854413A1 (de)	2011-07-06	2021-07-28	GlaxoSmithKline Biologicals SA	Immunogene kombinationszusammensetzungen und ihre verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR012448A1 (es) *	1997-04-18	2000-10-18	Ipsen Pharma Biotech	Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada
WO2003028661A2 (en) *	2001-10-03	2003-04-10	Chiron Corporation	Adjuvanted meningococcus compositions
DK1589934T3 (en) *	2003-01-06	2015-12-21	Corixa Corp	Certain AMINOAL COOLER GLUCOSAMINIDE PHOSPHATE COMPOUNDS AND APPLICATION
JP2006522806A (ja) *	2003-03-26	2006-10-05	マルチセル・イミュノセラピューティクス，インコーポレイテッド	細胞死及び／又はアポトーシスを誘導するための、選択されたｒｎａモチーフ

2006
- 2006-03-02 WO PCT/GB2006/000751 patent/WO2006092607A1/en not_active Ceased
- 2006-03-02 CA CA002599329A patent/CA2599329A1/en not_active Abandoned
- 2006-03-02 AU AU2006219717A patent/AU2006219717B2/en not_active Ceased
- 2006-03-02 JP JP2007557589A patent/JP2008531672A/ja active Pending
- 2006-03-02 US US11/885,538 patent/US20080138431A1/en not_active Abandoned
- 2006-03-02 EP EP06709975A patent/EP1853227B1/de not_active Expired - Lifetime
- 2006-03-02 AT AT06709975T patent/ATE438385T1/de not_active IP Right Cessation
- 2006-03-02 DE DE602006008278T patent/DE602006008278D1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO2006092607A1 (en)	2006-09-08
AU2006219717B2 (en)	2009-05-21
AU2006219717A1 (en)	2006-09-08
US20080138431A1 (en)	2008-06-12
EP1853227B1 (de)	2009-08-05
DE602006008278D1 (de)	2009-09-17
EP1853227A1 (de)	2007-11-14
CA2599329A1 (en)	2006-09-08
JP2008531672A (ja)	2008-08-14

Similar Documents

Publication	Publication Date	Title
Devi VK et al.	2021	Self-healing hydrogels: preparation, mechanism and advancement in biomedical applications
Yu et al.	2023	Smart polymeric nanoparticles in cancer immunotherapy
Rizwan et al.	2017	pH sensitive hydrogels in drug delivery: Brief history, properties, swelling, and release mechanism, material selection and applications
WO2007040469A3 (en)	2007-07-12	Chloroquine coupled compositions and methods for their synthesis
WO2009135190A3 (en)	2010-11-25	Therapeutic calcium phosphate particles and methods of making and using same
Pahwa et al.	2012	Chitosan-based gastroretentive floating drug delivery technology: an updated review
ATE424848T1 (de)	2009-03-15	Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen
MX2009005727A (es)	2009-08-27	Nanoparticulas de entidad anfifilica.
WO2008013785A3 (en)	2008-11-06	Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
MX2009011247A (es)	2010-01-29	Nanoparticulas que comprenden una ciclodextrina y una molecula biologicamente activa y sus aplicaciones.
WO2006060723A3 (en)	2007-04-19	Methods for producing block copolymer/amphiphilic particles
ATE522200T1 (de)	2011-09-15	Aripiprazole injektionsuspension
WO2004032862A3 (en)	2004-07-01	Cyclodextrin-based materials, compositions and uses related thereto
TW200635618A (en)	2006-10-16	Solid dosage form comprising proton pump inhibitor and suspension made thereof
DE602006008278D1 (de)	2009-09-17	Pharmazeutische zusammensetzung
GEP20115200B (en)	2011-04-11	Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same
EA201170039A1 (ru)	2011-12-30	Полимерные частицы, нагруженные лекарственным средством, и способы их получения и применения
DE602006014990D1 (de)	2010-07-29	Intranasale verabreichung von schnell wirkendem insulin
EA200900572A1 (ru)	2009-10-30	Мицеллярные наночастицы с химическими субстанциями
DE60312333D1 (de)	2007-04-19	Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
ATE459345T1 (de)	2010-03-15	Wirkstoffpartikelhaltiges transdermales therapeutisches system mit erhöhtem wirkstofffluss
WO2008085556A3 (en)	2008-10-16	Surfactant-free nanoparticles for drug delivery
WO2005055980A3 (en)	2006-01-05	Polymalic acid-based multifunctional drug delivery system
WO2023129738A3 (en)	2023-11-23	Modified polysaccharide polymers and related compositions and methods thereof
WO2006137856A3 (en)	2007-05-03	Method for the production of nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility

Legal Events

Date	Code	Title	Description
2010-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties